Top Pharmaceutical Companies (2,042)
AcuraStem is a patient-based biotechnology company dedicated to pioneering the development of treatments for neurodegenerative diseases, specifically amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Utilizing its proprietary iNeuroRx® disease-modeling platform, the company focuses on discovering novel, effective, and broadly acting treatments that address the mechanisms driving these diseases, particularly for sporadic cases where the genetic cause is unknown.
SeqMatic is a CRO Laboratory that provides superior end-to-end NGS, Multi-omics and histopathology workflow solutions including DNA, RNA, Single Cell, Epigenomics, Spatial, Histology & Bioinformatics. All work performed in Fremont, CA. Founded in 2012 by former Illumina R&D scientists. Certified by Illumina, 10x Genomics and Parse Biosciences. CLIA/CAP accredited laboratory with robust Quality Management Systems. Our work has been cited...
Neu-Ion, Inc. is a women-owned, family-run business that designs, builds, installs, and services high-purity water treatment systems. They provide tailored solutions for a variety of critical industries, including biotechnology, pharmaceuticals, healthcare, research, and industrial facilities. Specializing in the design and preventive maintenance of high-purity water systems, they ensure operational consistency, regulatory compliance, and long-term performance for their clients across the...
Omya is a leading global producer of industrial minerals, primarily fillers and pigments derived from calcium carbonate and dolomite, and a worldwide distributor of specialty materials. The company operates across diverse sectors, including construction, polymers, pulp and paper, agriculture, and life sciences. It provides high-purity minerals and specialty ingredients designed to improve process efficiency and performance for customers in over...
Callen-Lorde is the global leader in LGBTQ+ healthcare. Since the days of Stonewall, we have been transforming lives in LGBTQ+ communities through excellent comprehensive care, provided free of judgment and regardless of ability to pay. In addition, we are continuously pioneering research, advocacy and education to drive positive change around the world, because we believe healthcare is a human right.
PharmaLex is a leading provider of specialized services for the pharma, biotech and medtech industries. We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval/maintenance post-launch activities. Our experts use technology enabled solutions to support you through the entire product lifecycle. We deliver exceptional results - going above and beyond the standard...
PharmaLex's Top Stability & Growth Strengths
Strong Market Position & Advantage: Everest Group’s 2024 PEAK Matrix places Cencora PharmaLex in the Leaders category for life‑sciences regulatory and medical affairs operations alongside major peers. A global multi‑office footprint and end‑to‑end regulatory, pharmacovigilance, and quality services underpin credible multi‑region execution.
Strategic Partnerships: Integration into Cencora (formerly AmerisourceBergen) provides enterprise‑grade backing and access to a broader commercialization ecosystem. Prior bolt‑on acquisitions and alliances broadened capabilities in technology‑enabled services and market access across regions.
Market Expansion: The organization cites 60+ offices and a global delivery model enabling local regulatory execution across major markets while coordinating centrally. Pre‑ and post‑acquisition mergers expanded geographic presence in areas such as the Nordics and Australia/New Zealand.
Avantpage is a language access solutions provider specializing in professional translation, localization, and interpretation services in over 150 languages. The company serves government, healthcare, life sciences, and other regulated industries, focusing on bridging communication gaps for immigrants and Limited English Proficient populations to create equity and opportunity.
ReviveRX is a leading licensed mail-order pharmacy specializing in generic and compounded medications. Our compounds are expertly crafted in USP-certified clean rooms at our Houston headquarters, ensuring the highest quality standards. We work closely with best-in-class pharmacists, scientists, healthcare providers, and pharmaceutical manufacturers to provide high-quality, dependable products to our patients and clinic partners.
RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radio-pharmaceuticals based on Gallium-68 chemistry. RadioMedix is in late-stage development of a new radio-labeled analog targeting metabolic pathway, GlucoMedix, which is based on its patented DO2A-chelation technology. RadioMedix is introducing the SmartMedix™ automated laboratory...
Caprion Biosciences was a leading provider of proteomics and immune monitoring services to the pharmaceutical and biotechnology industry, specializing in advanced immunology and proteomics services. It has since rebranded to CellCarta, a global contract research organization.
NuvemRx is a tech-enabled pharmacy services and solutions company dedicated to helping community health providers. It simplifies pharmacy operations, combining expert services with advanced technology and analytics to illuminate savings, elevate patient care, and optimize financial results.
PeakData helps pharmaceutical companies learn more about their customers through our agile targeting and segmentation SaaS platform. PeakData is used by more than half of the top 20 Pharmaceuticals and engages 50+ staff in our offices in the USA, Germany, UK, Poland, Netherlands, and Switzerland.
PharmaForceIQ is an AI-driven real-time customer engagement platform built specifically for the life sciences and pharmaceutical industry. It unifies brand and field efforts by leveraging proprietary HCP affinity data and real-world signals to orchestrate hyper-targeted 'optichannel' marketing campaigns, enabling pharmaceutical companies to enhance HCP engagement, drive prescription lift, and optimize their marketing ROI.
HighRes Biosolutions is a leading global lab automation company specializing in the design and construction of innovative robotic systems and laboratory devices. They empower pharmaceutical, biotech, and academic research laboratories by automating workflows and unifying instrumentation, software, and data through their orchestration platforms. Their mission is to remove friction from science and accelerate the rate at which life science organizations...
Oxford BioTherapeutics (OBT) is a clinical stage oncology company based in Oxford, UK; San Jose, CA and Morristown, NJ, USA, with a pipeline of first-in-class immuno-oncology (IO) and antibody-drug conjugate (ADC) based therapies designed to fulfil major unmet patient needs in cancer therapeutics. Our lead asset, OBT076, is an Antibody Drug Conjugate (ADC) in Phase 1b clinical development. OBT076's...
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With 50 years in business, operations in more than 35 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled...
Cardinal Health's Top Stability & Growth Strengths
Strong Revenue Growth: Broad-based segment momentum is evident, with Pharmaceutical & Specialty Solutions and the “Other” businesses posting strong year-over-year revenue increases alongside profit expansion. Growth is further supported by increased specialty-pharmaceutical volumes and added distribution capacity for complex therapies.
Profitability: Segment profit and operating earnings are rising faster than revenue in recent periods, indicating improved earnings conversion. Management’s repeated increases to non-GAAP EPS guidance reinforce the view that profitability is strengthening.
Diversified Revenue Streams: Adjacency businesses (at-Home Solutions, Nuclear & Precision Health, OptiFreight) are growing quickly and contributing meaningfully to profit growth. Portfolio expansion through acquisitions is broadening the earnings base beyond core drug distribution.
PHC Group is a global company dedicated to improving health through digital and precision technology. It provides best-in-class products and services in diabetes management, healthcare solutions, diagnostics, and life sciences, supporting patients, healthcare professionals, and researchers in over 125 countries.
Edwards Lifesciences (NYSE: EW), is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales &...
Edwards Lifesciences's Top Stability & Growth Strengths
Strong Market Position & Advantage: Edwards is broadly characterized as the TAVR category leader anchored by the SAPIEN portfolio, and its first-to-approval EVOQUE tricuspid replacement reinforces leadership across structural heart. Industry trackers and company updates point to durable share and breadth across aortic, mitral, and tricuspid therapies.
Strong Revenue Growth: Recent results show double-digit top-line expansion and successive raises to the 2026 sales outlook, driven by steady TAVR demand and rapid TMTT growth. Management commentary emphasizes continued momentum with a consistent long-term growth ambition.
Innovation-Driven Growth: First-to-approval EVOQUE in tricuspid replacement, rapid uptake of PASCAL in mitral repair, and extensive long-term SAPIEN evidence position the portfolio for further adoption. Regulatory and policy catalysts, including a pending CMS TAVR coverage reconsideration and accumulating durability data, may expand access.
Herbaland Naturals Inc. is a Canadian family-owned natural health and wellness brand founded in 2009. As Canada's largest nutritional gummy manufacturer, it produces over 70 million vitamins, supplements, and functional snacks annually. Its mission is to bring health and wellness to everyone by creating natural health products that are functional, sustainable, and environmentally friendly, while ensuring prosperity for its employees.
